Judge Strikes Some Claims, Plaintiffs' Experts, in Ozempic Lawsuits
Judge Strikes Some Claims and Plaintiffs’ Experts in Ozempic Lawsuits: A Pivotal Development in GLP-1 Litigation In a significant ruling on August 18, 2025, a Pennsylvania federal judge overseeing the multidistrict litigation (MDL) involving Ozempic and other glucagon-like peptide-1 receptor agonists (GLP-1 RAs) struck several claims and disqualified two plaintiffs’ expert witnesses, reshaping the trajectory … Read more